Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

US Patent 11474112 · Granted Oct 18, 2022

Estimated economic value: $393,425,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PD1 and VEGFR2 dual-binding agents2025
CD47 binding agents2025
Anti C-MET antibodies2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025